Results 71 to 80 of about 18,233 (306)

Guided Tissue Regeneration in Heart Valve Replacement: From Preclinical Research to First-in-Human Trials [PDF]

open access: yes, 2015
Heart valve tissue-guided regeneration aims to offer a functional and viable alternative to current prosthetic replacements. Not requiring previous cell seeding and conditioning in bioreactors, such exceptional tissue engineering approach is a very ...
Gerosa, Gino, Iop, Laura
core   +4 more sources

Clinical outcomes, hemodynamics, and leaflet thrombosis following transcatheter aortic valve replacement with novel intra‐annular devices

open access: yesHealth Science Reports, Volume 8, Issue 2, February 2025.
Abstract Background The indication of transcatheter aortic valve replacement (TAVR) is becoming more prevalent among younger and lower‐risk patients. However, data on the latest intra‐annular TAVR devices are limited. This study aims to compare the short‐term clinical outcomes of two intra‐annular transcatheter aortic valve replacement (TAVR) devices ...
Juri Iwata   +8 more
wiley   +1 more source

Tratamento cirúrgico das valvopatias aórticas com bioprótese de pericárdio bovino sem suporte: resultados imediatos Surgical treatment of aortic valve disease with stentless bovine pericardium prosthesis: immediate results

open access: yesArquivos Brasileiros de Cardiologia, 2006
OBJETIVO: Apresentar os resultados imediatos e avaliar o desempenho clínico e hemodinâmico das biopróteses sem suporte de pericárdio bovino (stentless) em posição aórtica.
Wesley Ferreira de Araújo   +6 more
doaj   +1 more source

Changing trends in aortic valve procedures over the past ten years-from mechanical prosthesis via stented bioprosthesis to TAVI procedures-analysis of 50,846 aortic valve cases based on a Polish National Cardiac Surgery Database.

open access: yesJournal of Thoracic Disease, 2019
Background Aortic valve replacement (AVR) is one of the most common surgeries performed in cardiac surgery operating rooms. We present actual, real life trends from the last 10 years for AVR interventions based on a multicentre National Registry of ...
K. Bartus   +14 more
semanticscholar   +1 more source

CHA2DS2-VASc Score for Predicting Stroke and Thromboembolism in Patients With AF and Biological Valve Prosthesis [PDF]

open access: yes, 2016
International ...
Angoulvant, Denis   +8 more
core   +2 more sources

Two‐year clinical outcomes of Taiwanese and other Asian ethnicities with atrial fibrillation treated with edoxaban in the ETNA‐AF Asia registry

open access: yesJournal of Arrhythmia, Volume 41, Issue 1, February 2025.
In this sub‐analysis of the ETNA‐AF registry on Asian patients, the low clinical event rates in two‐year follow‐up reassure the effectiveness and safety of edoxaban in routine care for AF patients in Taiwan, South Korea, Hong Kong, and Thailand. Abstract Background The non‐vitamin K oral anticoagulant (NOAC), edoxaban, is approved for stroke prevention
Chun‐Chieh Wang   +11 more
wiley   +1 more source

Reticulação progressiva de pericárdio bovino com glutaraldeído para confecção de válvulas cardíacas biológicas The progressive crosslinking of collagen matrices with glutaraldehyde in the manufacture of biological cardiac valves

open access: yesPolímeros, 1998
Este trabalho descreve um novo processo para a reticulação de matrizes de colágeno com glutaraldeído para a preparação de materiais para a confecção de válvulas cardíacas biológicas, e consiste no tratamento do pericárdio bovino com concentrações ...
Gilberto Goissis   +4 more
doaj   +1 more source

Intermediate-term outcomes after aortic valve replacement with a novel RESILIATM tissue bioprosthesis.

open access: yesJournal of Thoracic Disease, 2019
Background The durability of bioprosthetic heart valves is limited by structural valve deterioration (SVD) due to long-term calcification. A novel bioprosthetic tissue (RESILIATM) has been developed which, in preclinical studies, has shown reduced ...
K. Bartus   +9 more
semanticscholar   +1 more source

Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prostheses [PDF]

open access: yes, 2008
ObjectiveImproved durability of bioprostheses has led some surgeons to recommend biologic rather than mechanical prostheses for patients younger than 65 years.
Brown, Morgan L.   +7 more
core   +1 more source

Accuracy of Three‐Dimensional Neo Left Ventricular Outflow Tract Simulations With Transcatheter Mitral Valve Replacement in Different Mitral Phenotypes

open access: yesCatheterization and Cardiovascular Interventions, Volume 105, Issue 1, Page 249-257, January 1, 2025.
ABSTRACT Background Transcatheter mitral valve replacement (TMVR) is emerging in the context of annular calcification (valve‐in‐MAC; ViMAC), failing surgical mitral annuloplasty (mitral‐valve‐in‐ring; MViR) and failing mitral bioprosthesis (mitral‐valve‐in‐valve; MViV).
Mark M. P. van den Dorpel   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy